News
Hims & Hers Health continues to fire on all cylinders as a business. Click here to read why HIMS stock is a Buy.
OMAHA, Neb. (WOWT) - The FDA is cracking down on off brand weight loss products similar to Ozempic. GLP-1 drugs for weight loss like Wegovy or Zepbound were previously in a shortage.
Health insurance plans are changing how they cover GLP-1 drugs for weight loss to rein in costs, forcing doctors and patients ...
Microdosing isn’t just popular for psychedelics. Some consumers are taking smaller than standard doses of GLP-1s—the popular ...
Cheaper alternatives to Ozempic and Wegovy may disappear as FDA reconsiders compounded drug loophole
SHREVEPORT, La. - Many people are using cheaper versions of popular weight-loss shots like Ozempic and Wegovy.
There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more ...
Explore more
As demand for GLP-1 weight-loss medications like Wegovy and Zepbound continues to grow in the United States, so do questions about their affordability.
(Reuters) -After years of easily available, cheap copies of Eli Lilly's and Novo Nordisk's highly effective weight-loss drugs ...
The U.S. Environmental Protection Agency has drafted a plan to eliminate all limits on greenhouse gases from coal and ...
A report published in November by KFF, a health information nonprofit that includes KFF Health News, found only 13 states were covering GLP-1s for the treatment of obesity for Medicaid beneficiaries ...
Recent health news includes major pharmaceutical listings in Hong Kong, a White House report on food and chemical impacts on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results